ADAG
Price
$2.18
Change
-$0.19 (-8.02%)
Updated
Aug 7 closing price
Capitalization
102.7M
19 days until earnings call
CYBN
Price
$7.55
Change
-$0.04 (-0.53%)
Updated
Aug 8, 10:30 AM (EDT)
Capitalization
178.71M
Interact to see
Advertisement

ADAG vs CYBN

Header iconADAG vs CYBN Comparison
Open Charts ADAG vs CYBNBanner chart's image
Adagene
Price$2.18
Change-$0.19 (-8.02%)
Volume$111.02K
Capitalization102.7M
Cybin
Price$7.55
Change-$0.04 (-0.53%)
Volume$643
Capitalization178.71M
ADAG vs CYBN Comparison Chart in %
Loading...
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAG vs. CYBN commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAG is a Hold and CYBN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (ADAG: $2.18 vs. CYBN: $7.59)
Brand notoriety: ADAG and CYBN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ADAG: 121% vs. CYBN: 69%
Market capitalization -- ADAG: $102.7M vs. CYBN: $178.71M
ADAG [@Biotechnology] is valued at $102.7M. CYBN’s [@Biotechnology] market capitalization is $178.71M. The market cap for tickers in the [@Biotechnology] industry ranges from $199.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAG’s FA Score shows that 0 FA rating(s) are green whileCYBN’s FA Score has 1 green FA rating(s).

  • ADAG’s FA Score: 0 green, 5 red.
  • CYBN’s FA Score: 1 green, 4 red.
According to our system of comparison, CYBN is a better buy in the long-term than ADAG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAG’s TA Score shows that 6 TA indicator(s) are bullish while CYBN’s TA Score has 2 bullish TA indicator(s).

  • ADAG’s TA Score: 6 bullish, 3 bearish.
  • CYBN’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ADAG is a better buy in the short-term than CYBN.

Price Growth

ADAG (@Biotechnology) experienced а +9.55% price change this week, while CYBN (@Biotechnology) price change was -1.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.18%. For the same industry, the average monthly price growth was +8.39%, and the average quarterly price growth was +12.02%.

Reported Earning Dates

ADAG is expected to report earnings on Aug 27, 2025.

Industries' Descriptions

@Biotechnology (+1.18% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYBN($179M) has a higher market cap than ADAG($103M). ADAG YTD gains are higher at: 9.548 vs. CYBN (-13.946). ADAG has higher annual earnings (EBITDA): -31.51M vs. CYBN (-134.52M). CYBN has more cash in the bank: 136M vs. ADAG (95.7M). CYBN has less debt than ADAG: CYBN (0) vs ADAG (20.8M). ADAG has higher revenues than CYBN: ADAG (816K) vs CYBN (0).
ADAGCYBNADAG / CYBN
Capitalization103M179M58%
EBITDA-31.51M-134.52M23%
Gain YTD9.548-13.946-68%
P/E RatioN/AN/A-
Revenue816K0-
Total Cash95.7M136M70%
Total Debt20.8M0-
FUNDAMENTALS RATINGS
CYBN: Fundamental Ratings
CYBN
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
18
Undervalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ADAGCYBN
RSI
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 3 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
Aroon
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
ADAG
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYBN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DQJCY36.190.25
+0.70%
Pan Pac Intl Hldgs Corp.
JTTRY15.34N/A
N/A
Japan Airport Terminal
PPZRF0.01N/A
N/A
SEASIF EXPLORATION INC.
IDGAF0.08N/A
N/A
5TH PLANET GAMES
KNMOF18.13N/A
N/A
Kanamoto Co Ltd.

ADAG and

Correlation & Price change

A.I.dvisor tells us that ADAG and TNFA have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ADAG and TNFA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAG
1D Price
Change %
ADAG100%
-8.02%
TNFA - ADAG
26%
Poorly correlated
-5.84%
QTTB - ADAG
24%
Poorly correlated
-8.21%
IBO - ADAG
23%
Poorly correlated
-3.94%
ENTA - ADAG
22%
Poorly correlated
-1.83%
CYBN - ADAG
22%
Poorly correlated
+1.74%
More

CYBN and

Correlation & Price change

A.I.dvisor indicates that over the last year, CYBN has been loosely correlated with ATAI. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CYBN jumps, then ATAI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYBN
1D Price
Change %
CYBN100%
+1.74%
ATAI - CYBN
42%
Loosely correlated
-0.95%
RXRX - CYBN
35%
Loosely correlated
-1.28%
ABSI - CYBN
33%
Loosely correlated
+0.34%
EYPT - CYBN
30%
Poorly correlated
-4.82%
ABCL - CYBN
29%
Poorly correlated
+2.67%
More